Your browser doesn't support javascript.
loading
Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study.
Grewal, Ramandip; Buchan, Sarah A; Nguyen, Lena; Nasreen, Sharifa; Austin, Peter C; Brown, Kevin A; Gubbay, Jonathan; Lee, Nelson; Schwartz, Kevin L; Tadrous, Mina; Wilson, Kumanan; Wilson, Sarah E; Kwong, Jeffrey C.
Afiliación
  • Grewal R; Public Health Ontario, Toronto.
  • Buchan SA; Dalla Lana School of Public Health, University of Toronto.
  • Nguyen L; Centre for Vaccine Preventable Diseases, University of Toronto.
  • Nasreen S; Public Health Ontario, Toronto.
  • Austin PC; Dalla Lana School of Public Health, University of Toronto.
  • Brown KA; Centre for Vaccine Preventable Diseases, University of Toronto.
  • Gubbay J; ICES, Toronto.
  • Lee N; ICES, Toronto.
  • Schwartz KL; Dalla Lana School of Public Health, University of Toronto.
  • Tadrous M; ICES, Toronto.
  • Wilson K; ICES, Toronto.
  • Wilson SE; Institute of Health Policy, Management and Evaluation, University of Toronto.
  • Kwong JC; Public Health Ontario, Toronto.
J Infect Dis ; 229(2): 394-397, 2024 Feb 14.
Article en En | MEDLINE | ID: mdl-37798119
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article